LBX Pharmacy Chain Joint Stock Company (SHA:603883)
19.26
+0.97 (5.30%)
Apr 1, 2025, 2:45 PM CST
SHA:603883 Revenue
LBX Pharmacy Chain Joint Stock Company had revenue of 5.29B CNY in the quarter ending September 30, 2024, with 1.18% growth. This brings the company's revenue in the last twelve months to 22.63B, up 0.84% year-over-year. In the year 2023, LBX Pharmacy Chain Joint Stock Company had annual revenue of 22.44B with 11.21% growth.
Revenue (ttm)
22.63B
Revenue Growth
+0.84%
P/S Ratio
0.64
Revenue / Employee
553.51K
Employees
40,881
Market Cap
14.59B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 22.44B | 2.26B | 11.21% |
Dec 31, 2022 | 20.18B | 4.48B | 28.54% |
Dec 31, 2021 | 15.70B | 1.73B | 12.38% |
Dec 31, 2020 | 13.97B | 2.30B | 19.75% |
Dec 31, 2019 | 11.66B | 2.19B | 23.15% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Jiangsu Hengrui Medicine | 27.98B |
Shenzhen Mindray Bio-Medical Electronics | 37.11B |
WuXi AppTec | 37.92B |
Aier Eye Hospital Group | 20.62B |
Zhangzhou Pientzehuang Pharmaceutical., | 10.91B |
Shanghai United Imaging Healthcare | 10.30B |
Yunnan Baiyao Group Co.,Ltd | 40.03B |
Sichuan Biokin Pharmaceutical | 5.82B |